Pharma-Bio Serv (PBSV) Change in Accured Expenses (2010 - 2026)
Pharma-Bio Serv (PBSV) posted Change in Accured Expenses of -$546515.0 for Q2 2026, down 269.13% on a QoQ basis from -$148056.0 in Q1 2026, and up 8.58% year-over-year from -$503312.2 in Q2 2025.
Pharma-Bio Serv (PBSV) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$546515.0 for Q2 2026.
- Quarterly Change in Accured Expenses rose 8.58% year-over-year to -$546515.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$736605.0 (up 39.15% YoY) and the FY2025 annual result came in at -$853006.0, up 29.35% from the prior year.
- Change in Accured Expenses was -$546515.0 for Q2 2026 at Pharma-Bio Serv, down from -$148056.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $170854.0 in Q3 2023 and bottomed at -$597831.0 in Q2 2025.
- A 5-year average of -$212887.1 and a median of -$200893.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 305.27% — and 2024, when it sank 1618.45%.
- Pharma-Bio Serv's Change in Accured Expenses stood at -$83385.0 in 2022, then sank by 285.47% to -$321427.0 in 2023, then soared by 83.03% to -$54545.0 in 2024, then surged by 245.93% to $79597.0 in 2025, then tumbled by 786.6% to -$546515.0 in 2026.
- Business Quant data shows PBSV's Change in Accured Expenses at -$546515.0 in Q2 2026, -$148056.0 in Q1 2026, and $79597.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 8.92 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 11.03 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | -873,000.00 |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | -20.60 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | -613,000.00 |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 67.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | -9.67 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | -35.25 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 49.11 Mn |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | -546,515.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -546,515.00 |
| Apr 30, 2026 | -546,515.00 |
| Jan 31, 2026 | -148,056.00 |
| Jan 31, 2026 | -148,056.00 |
| Oct 31, 2025 | 79,597.00 |
| Oct 31, 2025 | 79,597.00 |
| Jul 31, 2025 | -121,631.00 |
| Jul 31, 2025 | -121,631.00 |
| Apr 30, 2025 | -597,831.00 |
| Apr 30, 2025 | -597,831.00 |
| Jan 31, 2025 | -213,141.00 |
| Jan 31, 2025 | -213,141.00 |
| Oct 31, 2024 | -54,545.00 |
| Oct 31, 2024 | -54,545.00 |
| Jul 31, 2024 | -345,041.00 |
| Jul 31, 2024 | -345,041.00 |
| Apr 30, 2024 | -376,637.00 |
| Apr 30, 2024 | -376,637.00 |
| Jan 31, 2024 | -431,106.00 |
| Jan 31, 2024 | -431,106.00 |